article thumbnail

Risk adjusted net present value: What is the current valuation of Novo Nordisk’s (Insulin icodec + Semaglutide)?

Pharmaceutical Technology

(Insulin icodec + Semaglutide) is a recombinant peptide and recombinant protein commercialized by Novo Nordisk, with a leading Phase III program in Type 2 Diabetes.

Insulin 100
article thumbnail

Lilly grabs glucose-sensing insulin tech, buying Protomer in $1bn deal

pharmaphorum

Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the programme since then – it has just agreed to buy the company outright. . It was also responsible for the first recombinant insulin product – Humulin – which launched in 1982 and remains on sale.

Insulin 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Risk adjusted net present value: What is the current valuation of Novo Nordisk’s (Insulin icodec + Semaglutide)?

Pharmaceutical Technology

(Insulin icodec + Semaglutide) is a recombinant peptide and recombinant protein commercialized by Novo Nordisk, with a leading Phase III program in Type 2 Diabetes.

Insulin 100
article thumbnail

New type of oral capsule may one day replace insulin injection for diabetics

Medical Xpress

Scientists in Melbourne have designed a new type of oral capsule that could mean pain-free delivery of insulin and other protein drugs.

Insulin 75
article thumbnail

Alzheimer’s Research Shifts from Amyloid and Tau to Neuroinflammation, Other Causes

BioSpace

Research into Alzheimer’s disease is shifting from amyloid plaque and tau protein to neuroinflammation, white matter changes and insulin resistance.

Insulin 115
article thumbnail

What are the benefits of oral delivery of insulin and how can algae support candidate therapeutic proteins?

BioPharma Reporter

These are some of the questions we will be asking leading experts next week.

Insulin 94
article thumbnail

Scotland Introduces First C-Peptide Type 1 Diabetes Test

XTalks

The government of Scotland has rolled out a new C-peptide test for type 1 diabetes that could help patients monitor their insulin levels with greater accuracy. The test provides information about the amount of insulin a patient has in their body, which can help determine whether they can reduce or stop taking their insulin injections.

Insulin 98